🔎 Trials Near Me

Home › Chronic Myeloid Leukemia › Georgia › Atlanta

Chronic Myeloid Leukemia clinical trials in Atlanta, GA

5 studies for Chronic Myeloid Leukemia are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Atlanta VA Medical Center, Decatur · 6 mi away
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Ages 0 to 38 · All sexes · Updated Oct 1, 2026 · NCT06131801

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

RecruitingPhase 2Healthy volunteers welcome
  • Northside Hospital, Atlanta
Ages 18 to 75 · All sexes · Updated Mar 10, 2026 · NCT06059391

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

RecruitingPhase 1
  • Winship Cancer Institute, Emory University, Atlanta
Ages 18 and older · All sexes · Updated Nov 5, 2025 · NCT04260022

About Chronic Myeloid Leukemia

Chronic myeloid leukemia (CML) is a cancer of the white blood cells. It usually affects older adults. Learn about symptoms, genetics, and treatment.

More about Chronic Myeloid Leukemia on MedlinePlus

Chronic Myeloid Leukemia trials in other cities

Other studies in Atlanta

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.